OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain

Clinical trial NCT06068049 · RECRUITING

Trial details

NCT number: NCT06068049
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2023-07-28
Primary completion: 2029-06-15
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.